Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted treatment for ALS.
The research group led by Chinese Academician Jiazuan Ni (College of Life Sciences and Oceanography, Shenzhen University), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback